Customer matched zone "Lagos Delivery Options"
Sort by:
132177–132192 of 365305 Results
-
A delicious combination of home-made yoghurt and no preservatives. With a healthy treat, enjoy homemade tasty, creamy, thick yoghurt blended with alkama (wheat) and coconut. Go all natural, meet the new yoghurt with no preservatives. Enjoy the combination of taste and health. Type: Sweetened Size: 50clSku: 1744759877-2180
Furar Alkama & Coconut Sweetened Yoghurt 50cl
₦1,820.00 -
A delicious combination of home-made yoghurt and no preservatives. With a healthy treat, enjoy homemade tasty, creamy, thick yoghurt blended with alkama (wheat) and coconut. Go all natural, meet the new yoghurt with no preservatives. Enjoy the combination of taste and health. Suitable for diabetic patients. Type: Unsweetened Size: 1 Liter Pre-order at least a day beforeSku: 1744759873-2179
Furar Alkama & Coconut Unsweetened Yoghurt 1 Liter
₦2,600.00 -
A delicious combination of home-made yoghurt and no preservatives. With a healthy treat, enjoy homemade tasty, creamy, thick yoghurt blended with alkama (wheat) and coconut. Go all natural, meet the new yoghurt with no preservatives. Enjoy the combination of taste and health. Suitable for diabetic patients. Type: Unsweetened Size: 35cl Pre-order at least a day beforeSku: 1744759868-2178
Furar Alkama & Coconut Unsweetened Yoghurt 35cl
₦1,300.00 -
A delicious combination of home-made yoghurt and no preservatives. With a healthy treat, enjoy homemade tasty, creamy, thick yoghurt blended with alkama (wheat) and coconut. Go all natural, meet the new yoghurt with no preservatives. Enjoy the combination of taste and health. Suitable for diabetic patients. Type: Unsweetened Size: 50cl Pre-order at least a day beforeSku: 1744759863-2177
Furar Alkama & Coconut Unsweetened Yoghurt 50cl
₦1,820.00 -
SaleFurasep 0.2%Furasep 0.2% is indicated in the infectious conditions of the skin such as burns, wounds, ulcers, skin infections and skin grafting.Theropeutic ClassTopical Antibiotic preparationsPharmacologyFurasep 0.2% is a broad spectrum topical antibacterial agent indicated for the treatment of mixed skin infections of superficial wounds and diseases of the skin.Dosage & Administration of Furasep 0.2%To be applied directly to the lesion or on gauze first; 2-3 times daily or as advised by the physician.Dosage of Furasep 0.2%To be applied directly to the lesion or on gauze first; 2-3 times daily or as advised by the physician.ContraindicationsFurasep 0.2% is contraindicated to patients with known sensitivity to Furasep 0.2%. It is not advisable to use Furasep 0.2% after the infection is cured. It should be used with caution in patients with known or suspected renal impairment.Side Effects of Furasep 0.2%Sensitization and generalized allergic skin reactions may be produced after few days of initial application. Cross sensitization to other Furasep 0.2% derivatives may occur. Intolerance to Furasep 0.2% necessitating withdrawal has been encountered.Pregnancy & LactationPregnancy category- BPrecautions & WarningsG6PD deficiency,?renal impairment.Drug ClassesTopical Antibiotic preparationsMode Of ActionFurasep 0.2% is a broad spectrum topical antibacterial agent indicated for the treatment of mixed skin infections of superficial wounds and diseases of the skin.PregnancyPregnancy category- BSku: 1736093814-527
Furasep0.2%
₦935.00Original price was: ₦935.00.₦841.50Current price is: ₦841.50. -
SaleThere are no reviews for this product.Write a review Your Name Your ReviewNote: HTML is not translated! Rating Bad Good Captcha Please complete the captcha validation below ContinueSku: 1721363015-6516
Furazabol 50MG
₦16,445.00Original price was: ₦16,445.00.₦1,430.00Current price is: ₦1,430.00.₦16,445.00Original price was: ₦16,445.00.₦1,430.00Current price is: ₦1,430.00. Add to basket Quick View -
Ingredients & Concentrations: Diloxanide 250 mg + Metronidazole 200 mg How to use: 1 tablet 3 times daily after meals Brand: EIPICO On Sale: No Weight: 0 Short Description: Diloxanide 250 mg + Metronidazole 200 mg Product Indication(s): Bacterial infections;Diarrhea Product Ingredient(s): Diloxanide furoate ;Metronidazole Product Functions: Antibacterial;Antidiarrheal Type of Product: Self care (OTC) Product form: Tablet Units Per Pack: 2 Count per Pack: 20 Product Origin: Local Disclaimer: Consult with your healthcare professional before taking any medication, to ensure the information displayed on this page applies to your personal circumstances;Every effort has been made to ensure that the information provided is accurate, up-to-date and complete, but no guarantee is made to that effect;All medications are dispensed from legal pharmacies licensed by the Ministry of health of the Arab Republic of Egypt. Caution Warnings: Keep Away from Children & Pets;Do not use damaged tablet Size: 19Sku: 1718149913-981
Furazol – 20 Tablets
₦8.30 -
SaleFurex 250 mgIt is indicated for the treatment of infections caused by sensitive bacteria. Pharyngitis/Tonsillitis caused by Streptococcus pyogenes. Acute Bacterial Otitis Media caused by Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis (beta-lactamase producing strains) or Streptococcus pyogenes. ... Read moreIt is indicated for the treatment of infections caused by sensitive bacteria. Pharyngitis/Tonsillitis caused by Streptococcus pyogenes. Acute Bacterial Otitis Media caused by Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis (beta-lactamase producing strains) or Streptococcus pyogenes. Acute bacterial maxillary sinusitis caused by Streptococcus pneumoniae or Haemophilus influenzae (non beta-lactamase producing strains) Lower respiratory tract infections including pneumoniae, caused by Streptococcus pneumoniae, Haemophilus influenzae (including beta lactamase-producing strains), Klebsiella spp., Staphylococcus aureus (penicillinase- and non-penicillinase-producing strains), Streptococcus pyogenes, E. coli Acute bacterial exacerbation of chronic bronchitis and Secondary bacterial infections of Acute bronchitis caused by Streptococcus pneumoniae, Haemophilus influenzae (beta-lactamase negative strains) or Haemophilus parainfluenzae (beta-lactamase negative strains). Skin and skin-structure infections caused by Staphylococcus aureus (including beta-lactamase producing strains) or Streptococcus pyogenes. Urinary tract infections caused by E.coli or Klebsiella pneumoniae. Bone and Joint Infections caused by Staphylococcus aureus (penicillinase- and non-penicillinase-producing strains). Gonorrhoea caused by penicillinase-producing and non-penicillinase producing strains of Neisseria gonorrhoeae. Early Lyme Disease (erythema migrans) caused by Borrelia burgdorferi. Theropeutic ClassSecond generation CephalosporinsPharmacologyCefuroxime is a well-characterized and effective antibacterial agent, which has broad-spectrum bactericidal activity against a wide range of common pathogens, including ?-lactamase producing strains. Cefuroxime has good stability to bacterial ?-lactamase and consequently, is active against many ampicillin-resistant and amoxycillin-resistant strains.Dosage of Furex 250 mgTablet or Suspension- Adolescents and adults (13 years and older)- Pharyngitis/tonsillitis: 250 mg b.i.d. for 5-10 days Acute bacterial maxillary sinusitis: 250 mg b.i.d. for 10 days Acute bacterial exacerbation of chronic bronchitis: 250-500 mg b.i.d. for 10 days Secondary bacterial infections of acute bronchitis: 250-500 mg b.i.d. for 5-10 days Uncomplicated skin and skin structure infections: 250-500 mg b.i.d. for 10 days Uncomplicated urinary tract infections: 250 mg b.i.d. for 7-10 days Uncomplicated Gonorrhoea: 1000 mg Single dose Community acquired pneumonia: 250-500 mg b.i.d. for 5-10 days MDR Typhoid Fever: 500 mg b.i.d. for 10-14 days Early Lyme disease: 500 mg b.i.d. for 20 days Paediatric Patients (3 months to 12 years)- Pharyngitis/Tonsillitis: 20 mg/kg/day b.i.d for 5-10 days Acute otitis media: 30 mg/kg/day b.i.d for 10 days Acute bacterial maxillary sinusitis: 30 mg/kg/day b.i.d for 10 days Impetigo: 30 mg/kg/day b.i.d for 10 days Parenteral- Adult: 750 mg three times daily by IM or IV injection. In severe infections, dose can be increased upto 1.5 gm three times daily by IV injection. The frequency may be increased to four times daily, if necessary, giving total daily doses of 3 to 6 gms. Children (above 3 months of age): 30 - 100 mg/kg/day given in 3 or 4 equally divided doses. A dose of 60 mg/kg/day is appropriate for most infections. Neonate: 30 - 100 mg/kg/day given in 2 or 3 equally divided doses. Surgical prophylaxis: 1.5 gm by IV injection at induction of anaesthesia; up to 3 further doses of 750 mg may be given by IV/IM injection every 8 hours for high risk procedures. Pneumonia: 1.5 gm IV injection twice daily for 2-3 days, followed by 500 mg twice daily (oral) for 7-10 days. Acute exacerbations of chronic bronchitis: 750 mg twice daily (IM or IV injection) for 2-3 days, followed by 500 mg twice daily (oral) for 5-10 days. (Duration of both parenteral and oral therapy is determined by the severity of the infection and the clinical status of the patient.) In Gonorrhoea: Adult: 1.5 gm as a single dose (as 2 x 750mg injections intramuscularly with different sites, e.g. each buttock). In Meningitis: Adult: 3 gm IV injection three times daily. Children (above 3 months of age): 200-240 mg/kg/day by IV injection in 3 or 4 divided doses reduced to 100 mg/kg/day after 3 days or on clinical improvement. Neonate: 100 mg/kg/day by IV injection at initial dose, reduced to 50 mg/kg/day, When clinically indicated. In bone and joint infections: Adult: 1.5 gm IV injection four times daily. Children (above 3 months of age): 150 mg/kg/day (not to exceed the maximum adult dose) in equally divided doses every 8 hours. Administration of Furex 250 mgThe use of freshly reconstituted solution is recommended. However, it maintains potency for at least 24 hours at room temperature or 48 hours at 5o CInteraction of Furex 250 mgNo potentially hazardous interactions have been reported.ContraindicationsCefuroxime is contraindicated in patients with known allergy to Cephalosporins.Side Effects of Furex 250 mgAdverse effects to Cefuroxime have occurred infrequently and have been generally mild and transient in nature. Effects reported include rashes and gastrointestinal disturbances. As with other antibiotics, prolonged use may result in the overgrowth of non susceptible organisms e.g. Candida.Pregnancy & LactationUS FDA pregnancy category of Cefuroxime is B. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed. Cefuroxime have been shown to be excreted in human milk. So, caution should be exercised when Cefuroxime is administered to a nursing woman.Precautions & WarningsCefuroxime should be given with care to patients receiving concurrent treatment with potent diuretics & who has history of colitis. Cephalosporin antibiotics may in general be given safely to patients who are hypersensitive to penicillin although cross reactions have reported. Cefuroxime has shown, that is not likely to be a problem at the recommended to dose levels.Storage ConditionsStore in a cool, dry place (below 30o C), away from light & moisture. Keep out of the reach of children.ReconstitutionFor 750 mg intramuscular injection: Add 3 ml water for injection to vial and then shake gently for dispersion.For 750 mg intravenous injection: Add 8 ml water for injection to vial and then shake gently for dispersion. The solution should be slowly injected directly into a vein over a 3 to 5 minutes period.For 1.5 g intravenous injection: Add 16 ml Water for injection to vial and then shake gently for dispersion. The solution should be slowly injected directly into a vein over a 3 to 5 minutes period.Drug ClassesSecond generation CephalosporinsMode Of ActionCefuroxime is a well-characterized and effective antibacterial agent, which has broad-spectrum bactericidal activity against a wide range of common pathogens, including ?-lactamase producing strains. Cefuroxime has good stability to bacterial ?-lactamase and consequently, is active against many ampicillin-resistant and amoxycillin-resistant strains.PregnancyUS FDA pregnancy category of Cefuroxime is B. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed. Cefuroxime have been shown to be excreted in human milk. So, caution should be exercised when Cefuroxime is administered to a nursing woman.Sku: 1736094967-818
Furex250 mg
₦1,380.50Original price was: ₦1,380.50.₦1,242.45Current price is: ₦1,242.45.₦1,380.50Original price was: ₦1,380.50.₦1,242.45Current price is: ₦1,242.45. Add to basket Quick View -
SaleFurex 500 mgIt is indicated for the treatment of infections caused by sensitive bacteria. Pharyngitis/Tonsillitis caused by Streptococcus pyogenes. Acute Bacterial Otitis Media caused by Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis (beta-lactamase producing strains) or Streptococcus pyogenes. ... Read moreIt is indicated for the treatment of infections caused by sensitive bacteria. Pharyngitis/Tonsillitis caused by Streptococcus pyogenes. Acute Bacterial Otitis Media caused by Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis (beta-lactamase producing strains) or Streptococcus pyogenes. Acute bacterial maxillary sinusitis caused by Streptococcus pneumoniae or Haemophilus influenzae (non beta-lactamase producing strains) Lower respiratory tract infections including pneumoniae, caused by Streptococcus pneumoniae, Haemophilus influenzae (including beta lactamase-producing strains), Klebsiella spp., Staphylococcus aureus (penicillinase- and non-penicillinase-producing strains), Streptococcus pyogenes, E. coli Acute bacterial exacerbation of chronic bronchitis and Secondary bacterial infections of Acute bronchitis caused by Streptococcus pneumoniae, Haemophilus influenzae (beta-lactamase negative strains) or Haemophilus parainfluenzae (beta-lactamase negative strains). Skin and skin-structure infections caused by Staphylococcus aureus (including beta-lactamase producing strains) or Streptococcus pyogenes. Urinary tract infections caused by E.coli or Klebsiella pneumoniae. Bone and Joint Infections caused by Staphylococcus aureus (penicillinase- and non-penicillinase-producing strains). Gonorrhoea caused by penicillinase-producing and non-penicillinase producing strains of Neisseria gonorrhoeae. Early Lyme Disease (erythema migrans) caused by Borrelia burgdorferi. Theropeutic ClassSecond generation CephalosporinsPharmacologyCefuroxime is a well-characterized and effective antibacterial agent, which has broad-spectrum bactericidal activity against a wide range of common pathogens, including ?-lactamase producing strains. Cefuroxime has good stability to bacterial ?-lactamase and consequently, is active against many ampicillin-resistant and amoxycillin-resistant strains.Dosage of Furex 500 mgTablet or Suspension- Adolescents and adults (13 years and older)- Pharyngitis/tonsillitis: 250 mg b.i.d. for 5-10 days Acute bacterial maxillary sinusitis: 250 mg b.i.d. for 10 days Acute bacterial exacerbation of chronic bronchitis: 250-500 mg b.i.d. for 10 days Secondary bacterial infections of acute bronchitis: 250-500 mg b.i.d. for 5-10 days Uncomplicated skin and skin structure infections: 250-500 mg b.i.d. for 10 days Uncomplicated urinary tract infections: 250 mg b.i.d. for 7-10 days Uncomplicated Gonorrhoea: 1000 mg Single dose Community acquired pneumonia: 250-500 mg b.i.d. for 5-10 days MDR Typhoid Fever: 500 mg b.i.d. for 10-14 days Early Lyme disease: 500 mg b.i.d. for 20 days Paediatric Patients (3 months to 12 years)- Pharyngitis/Tonsillitis: 20 mg/kg/day b.i.d for 5-10 days Acute otitis media: 30 mg/kg/day b.i.d for 10 days Acute bacterial maxillary sinusitis: 30 mg/kg/day b.i.d for 10 days Impetigo: 30 mg/kg/day b.i.d for 10 days Parenteral- Adult: 750 mg three times daily by IM or IV injection. In severe infections, dose can be increased upto 1.5 gm three times daily by IV injection. The frequency may be increased to four times daily, if necessary, giving total daily doses of 3 to 6 gms. Children (above 3 months of age): 30 - 100 mg/kg/day given in 3 or 4 equally divided doses. A dose of 60 mg/kg/day is appropriate for most infections. Neonate: 30 - 100 mg/kg/day given in 2 or 3 equally divided doses. Surgical prophylaxis: 1.5 gm by IV injection at induction of anaesthesia; up to 3 further doses of 750 mg may be given by IV/IM injection every 8 hours for high risk procedures. Pneumonia: 1.5 gm IV injection twice daily for 2-3 days, followed by 500 mg twice daily (oral) for 7-10 days. Acute exacerbations of chronic bronchitis: 750 mg twice daily (IM or IV injection) for 2-3 days, followed by 500 mg twice daily (oral) for 5-10 days. (Duration of both parenteral and oral therapy is determined by the severity of the infection and the clinical status of the patient.) In Gonorrhoea: Adult: 1.5 gm as a single dose (as 2 x 750mg injections intramuscularly with different sites, e.g. each buttock). In Meningitis: Adult: 3 gm IV injection three times daily. Children (above 3 months of age): 200-240 mg/kg/day by IV injection in 3 or 4 divided doses reduced to 100 mg/kg/day after 3 days or on clinical improvement. Neonate: 100 mg/kg/day by IV injection at initial dose, reduced to 50 mg/kg/day, When clinically indicated. In bone and joint infections: Adult: 1.5 gm IV injection four times daily. Children (above 3 months of age): 150 mg/kg/day (not to exceed the maximum adult dose) in equally divided doses every 8 hours. Administration of Furex 500 mgThe use of freshly reconstituted solution is recommended. However, it maintains potency for at least 24 hours at room temperature or 48 hours at 5o CInteraction of Furex 500 mgNo potentially hazardous interactions have been reported.ContraindicationsCefuroxime is contraindicated in patients with known allergy to Cephalosporins.Side Effects of Furex 500 mgAdverse effects to Cefuroxime have occurred infrequently and have been generally mild and transient in nature. Effects reported include rashes and gastrointestinal disturbances. As with other antibiotics, prolonged use may result in the overgrowth of non susceptible organisms e.g. Candida.Pregnancy & LactationUS FDA pregnancy category of Cefuroxime is B. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed. Cefuroxime have been shown to be excreted in human milk. So, caution should be exercised when Cefuroxime is administered to a nursing woman.Precautions & WarningsCefuroxime should be given with care to patients receiving concurrent treatment with potent diuretics & who has history of colitis. Cephalosporin antibiotics may in general be given safely to patients who are hypersensitive to penicillin although cross reactions have reported. Cefuroxime has shown, that is not likely to be a problem at the recommended to dose levels.Storage ConditionsStore in a cool, dry place (below 30o C), away from light & moisture. Keep out of the reach of children.ReconstitutionFor 750 mg intramuscular injection: Add 3 ml water for injection to vial and then shake gently for dispersion.For 750 mg intravenous injection: Add 8 ml water for injection to vial and then shake gently for dispersion. The solution should be slowly injected directly into a vein over a 3 to 5 minutes period.For 1.5 g intravenous injection: Add 16 ml Water for injection to vial and then shake gently for dispersion. The solution should be slowly injected directly into a vein over a 3 to 5 minutes period.Drug ClassesSecond generation CephalosporinsMode Of ActionCefuroxime is a well-characterized and effective antibacterial agent, which has broad-spectrum bactericidal activity against a wide range of common pathogens, including ?-lactamase producing strains. Cefuroxime has good stability to bacterial ?-lactamase and consequently, is active against many ampicillin-resistant and amoxycillin-resistant strains.PregnancyUS FDA pregnancy category of Cefuroxime is B. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed. Cefuroxime have been shown to be excreted in human milk. So, caution should be exercised when Cefuroxime is administered to a nursing woman.Sku: 1736097008-1377
Furex500 mg
₦17,380.00Original price was: ₦17,380.00.₦15,642.00Current price is: ₦15,642.00.₦17,380.00Original price was: ₦17,380.00.₦15,642.00Current price is: ₦15,642.00. Add to basket Quick View -
SaleProduct OverviewFurfural extrapure AR, ACS, 99%98-01-1Molecular Formula : C5H4O2 Molecular Weight : 96.09 Part B Storage : Room Temperature Shelf Life : 60 Months HSN Code : 29122990 IMDG Identification :UN No.:1199 , IMCO Class No.:6.1(3) , Packing Group:IIPackage Size: 500 ML ??? ?Product More SpecificationsMade InIndiaThere are no reviews for this product.Write a review Your Name Your ReviewNote: HTML is not translated! Rating Bad Good Captcha Please complete the captcha validation below ContinueSku: 1721363012-6515
Furfural extrapure AR, ACS, 99%, 500 ML
₦161.00Original price was: ₦161.00.₦140.00Current price is: ₦140.00. -
505122 cas: 98?01?1 fema: 2489 ec: 202?627?7flavis: 13.018coe: 2014jecfa: 450Sku: 1713928006-869
Furfural Natural
₦100.00 -
500851 cas: 98?00?0 fema: 2491 ec: 202?626?1flavis: 13.019coe: 2023jecfa: 451Sku: 1713928003-868
Furfuryl Alcohol
₦100.00 -
-
507885 cas: 13678?68?7 fema: 3162 ec: 237?173?9flavis: 13.033coe: 2250jecfa: 1074Sku: 1713927995-866
Furfuryl Thioacetate
₦100.00